(Q36909258)

17 August 2017

1 reference

title

A pharmacogenomic evaluation of migraine therapy (English)

1 reference

17 August 2017

1 reference

1 reference

4

1 reference

17 August 2017

Matthew P Johnson

1

1 reference

17 August 2017

Francesca Fernandez

series ordinal

2

1 reference

17 August 2017

Natalie J Colson

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

published in

1 reference

17 August 2017

volume

8

1 reference

17 August 2017

issue

12

1 reference

17 August 2017

page(s)

1821-1835

1 reference

Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Neurobiology of migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Migraine--current understanding and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Advances in pharmacological treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Advances in the understanding of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Zolmitriptan nasal spray provides fast relief of migraine symptoms and is preferred by patients: a Swedish study of preference in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Chronic ergot toxicity: A rare cause of lower extremity ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Ergot and triptan overuse in Austria--an evaluation of clinical data and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Migraine: emerging treatment options for preventive and acute attack therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

The global burden of migraine: measuring disability in headache disorders with WHO's Classification of Functioning, Disability and Health (ICF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A susceptibility locus for migraine with aura, on chromosome 4q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Localization of a gene for migraine without aura to chromosome 4q21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Evidence of a genetic factor in migraine with aura: a population-based Danish twin study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Migraine without aura and migraine with aura are inherited disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Familial migraine with and without aura: clinical characteristics and co-occurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Migraine and tension-type headache in a general population: precipitating factors, female hormones, sleep pattern and relation to lifestyle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Evidence for an X-linked genetic component in familial typical migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A locus for migraine without aura maps on chromosome 14q21.2-q22.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A gene for familial hemiplegic migraine maps to chromosome 19

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Significant linkage to migraine with aura on chromosome 11q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A new susceptibility locus for migraine with aura in the 15q11-q13 genomic region containing three GABA-A receptor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A genome-wide scan provides evidence for loci influencing a severe heritable form of common migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Genomewide significant linkage to migrainous headache on chromosome 5q21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Trait components provide tools to dissect the genetic susceptibility of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Migraine association and linkage analyses of the human 5-hydroxytryptamine (5HT2A) receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Genotype influences in vivo dopamine transporter availability in human striatum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A genetic association study of migraine with dopamine receptor 4, dopamine transporter and dopamine-beta-hydroxylase genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Dopamine receptor genes and migraine with and without aura: an association study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

The -141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Significance of the catechol-O-methyltransferase gene polymorphism in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

The association between headache and Val158Met polymorphism in the catechol-O-methyltransferase gene: the HUNT Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

The functional Val158Met variant of the COMT gene is not associated with migraine with or without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Familial migraine with aura: association study with 5-HT1B/1D, 5-HT2C, and hSERT polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Association of the T102C polymorphism of 5-HT2A receptor gene with aura in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

An investigation of the 5-HT2C receptor gene as a migraine candidate gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A genetic analysis of serotonergic biosynthetic and metabolic enzymes in migraine using a DNA pooling approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A polymorphism in the serotonin transporter gene regulatory region and frequency of migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Altered allelic distributions of the serotonin transporter gene in migraine without aura and migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Significance of serotonin transporter gene polymorphism in migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Glutathione S-Transferase Polymorphisms: Susceptibility to Migraine without Aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Tumor necrosis factor B gene polymorphism contributes to susceptibility to migraine without area

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Association between the tumor necrosis factor-alpha -308 G/A gene polymorphism and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Investigation of hormone receptor genes in migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Association of the insertion/deletion polymorphism of the angiotensin I-converting enzyme gene in patients of migraine with aura.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Genetic variants of angiotensin converting enzyme and methylenetetrahydrofolate reductase may act in combination to increase migraine susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Association of the C677T and A1298C polymorphisms in the 5,10 methylenetetrahydrofolate reductase gene in patients with migraine risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Migraine and MTHFR C677T genotype in a population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

The relationship of migraine and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Evaluation of the interactions of common genetic mutations in stroke subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Nitric oxide: a new messenger in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Investigation of an LDLR gene polymorphism (19p13.2) in susceptibility to migraine without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Single-nucleotide polymorphism alleles in the insulin receptor gene are associated with typical migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Folic acid says NO to vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Topiramate in migraine prevention: evidence-based medicine from clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Divalproex sodium in migraine prophylaxis: a dose-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Baclofen for prevention of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Glutamate and nitric oxide pathway in chronic daily headache: evidence from cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Ovarian hormones and migraine headache: understanding mechanisms and pathogenesis--part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Estrogen is more than just a "sex hormone": novel sites for estrogen action in the hippocampus and cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Influence of sex steroid hormones on cerebrovascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Estradiol supplementation modulates neuroendocrine response to M-chlorophenylpiperazine in menstrual status migrainosus triggered by oral contraception-free interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Pregnanolone emulsion. A new steroid preparation for intravenous anaesthesia: an experimental study in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Differential effects of progestins on the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Anesthetic effects of progesterone are undiminished in progesterone receptor knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Progesterone receptor-mediated effects of neuroactive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Headaches in women undergoing in vitro fertilization and embryo-transfer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Headaches in the first post partum week and their relationship to migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Oestrogen and attacks of migraine with and without aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Migraine and reporoductive hormones throughout the menstrual cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

A novel specific prophylaxis for menstrual-associated migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Allelic variation in the serotonin 5-HT2C receptor gene and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

Testing of Variants of the MTHFR and ESR1 Genes in 1798 Finnish Individuals Fails to Confirm the Association with Migraine with Aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1821

10.1517/14656566.8.12.1821

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference